Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19
Clinical Infectious Diseases · 2024
DOI: 10.1093/cid/ciad780 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Infectious Diseases, 2024. Verfasst von Neil R Aggarwal und 30 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Hospitalization, Interleukin-6. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institute of Allergy and Infectious Diseases, NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Background
Persistent mortality in adults hospitalized due to acute COVID-19 justifies pursuit of disease mechanisms and potential therapies. The aim was to evaluate which virus and host response factors were associated with mortality risk among participants in Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3) trials.
Methods
A secondary analysis of 2625 adults hospitalized for acute SARS-CoV-2 infection randomized to 1 of 5 antiviral products or matched placebo in 114 centers on 4 continents. Uniform, site-level collection of participant baseline clinical variables was performed. Research laboratories assayed baseline upper respiratory swabs for SARS-CoV-2 viral RNA and plasma for anti–SARS-CoV-2 antibodies, SARS-CoV-2 nucleocapsid antigen (viral Ag), and interleukin-6 (IL-6). Associations between factors and time to mortality by 90 days were assessed using univariate and multivariable Cox proportional hazards models.
Results
Viral Ag ≥4500 ng/L (vs <200 ng/L; adjusted hazard ratio [aHR], 2.07; 1.29–3.34), viral RNA (<35 000 copies/mL [aHR, 2.42; 1.09–5.34], ≥35 000 copies/mL [aHR, 2.84; 1.29–6.28], vs below detection), respiratory support (<4 L O2 [aHR, 1.84; 1.06–3.22]; ≥4 L O2 [aHR, 4.41; 2.63–7.39], or noninvasive ventilation/high-flow nasal cannula [aHR, 11.30; 6.46–19.75] vs no oxygen), renal impairment (aHR, 1.77; 1.29–2.42), and IL-6 >5.8 ng/L (aHR, 2.54 [1.74–3.70] vs ≤5.8 ng/L) were significantly associated with mortality risk in final adjusted analyses. Viral Ag, viral RNA, and IL-6 were not measured in real-time.
Conclusions
Baseline virus-specific, clinical, and biological variables are strongly associated with mortality risk within 90 days, revealing potential pathogen and host-response therapeutic targets for acute COVID-19 disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
- Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.
- Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
- CAMRIS International (under contract no. 75N93019D00025 with National Institute of Allergy and Infectious Diseases, Department of Health and Human Services), National Institute of Health, Bethesda, Maryland, USA.
- Velocity Clinical Research, Chula Vista, California, USA.
- Department of General Internal Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
ORCID-Profile: Neil R Aggarwal
Förderung
- National Institute of Allergy and Infectious Diseases
- NIH HHS
- NHLBI NIH HHS
- University of Minnesota
- NIAID NIH HHS
- NCI NIH HHS
- National Institutes of Health
- National Cancer Institute
Zitieren
APA
Aggarwal, N. R., Nordwall, J., Braun, D. L., Chung, L., Coslet, J., Der, T., Eriobu, N., Ginde, A. A., Hayanga, A. J., Highbarger, H., Holodniy, M., Horcajada, J. P., Jain, M. K., Kim, K., Laverdure, S., Lundgren, J., Natarajan, V., Nguyen, H. H., Pett, S. L., …, & ACTIV-3/TICO Study Group (2024). Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad780
Vancouver
Aggarwal NR, Nordwall J, Braun DL, Chung L, Coslet J, Der T, et al. Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciad780
BibTeX
@article{Aggarwal2024,
author = {Aggarwal, Neil R and Nordwall, Jacquie and Braun, Dominique L and Chung, Lucy and Coslet, Jordan and Der, Tatyana and Eriobu, Nnakelu and Ginde, Adit A and Hayanga, Awori J and Highbarger, Helene and Holodniy, Mark and Horcajada, Juan P and Jain, Mamta K and Kim, Kami and Laverdure, Sylvain and Lundgren, Jens and Natarajan, Ven and Nguyen, Hien H and Pett, Sarah L and Phillips, Andrew and Poulakou, Garyphallia and Price, David A and Robinson, Philip and Rogers, Angela J and Sandkovsky, Uriel and Shaw-Saliba, Katy and Sturek, Jeffrey M and Trautner, Barbara W and Waters, Michael and Reilly, Cavan and ACTIV-3/TICO Study Group, ACTIV-3/TICO Study Group},
title = {Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19},
journal = {Clinical Infectious Diseases},
year = {2024},
doi = {10.1093/cid/ciad780}
}
EUVIMED